Published in Blood on November 09, 2007
Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients. Oncol Lett (2012) 1.10
Clinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome. Clin Exp Immunol (2008) 1.05
Effects of 4-hydroxynonenal on vascular endothelial and smooth muscle cell redox signaling and function in health and disease. Redox Biol (2013) 1.04
RLIP76: A novel glutathione-conjugate and multi-drug transporter. Biochem Pharmacol (2008) 0.99
Management of cardiovascular disease risk in chronic inflammatory disorders. Nat Rev Rheumatol (2009) 0.98
RLIP76: a versatile transporter and an emerging target for cancer therapy. Biochem Pharmacol (2010) 0.97
RALBP1/RLIP76 depletion in mice suppresses tumor growth by inhibiting tumor neovascularization. Cancer Res (2012) 0.90
Ras family of small GTPases in immunity and inflammation. Curr Opin Pharmacol (2012) 0.82
Rho GAPs and GEFs: controling switches in endothelial cell adhesion. Cell Adh Migr (2014) 0.82
An innovative method to identify autoantigens expressed on the endothelial cell surface: serological identification system for autoantigens using a retroviral vector and flow cytometry (SARF). Clin Dev Immunol (2013) 0.80
The RLIP76 N-terminus binds ARNO to regulate PI 3-kinase, Arf6 and Rac signaling, cell spreading and migration. Biochem Biophys Res Commun (2014) 0.79
Streptococcal-vimentin cross-reactive antibodies induce microvascular cardiac endothelial proinflammatory phenotype in rheumatic heart disease. Clin Exp Immunol (2013) 0.78
RLIP76 regulates Arf6-dependent cell spreading and migration by linking ARNO with activated R-Ras at recycling endosomes. Biochem Biophys Res Commun (2015) 0.78
Emerging treatments in lung cancer - targeting the RLIP76 molecular transporter. Lung Cancer (Auckl) (2013) 0.77
Annexin A2 as a target endothelial cell membrane autoantigen in Behçet's disease. Sci Rep (2015) 0.76
RLIP76 regulates HIF-1 activity, VEGF expression and secretion in tumor cells, and secretome transactivation of endothelial cells. FASEB J (2014) 0.76
Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients. Arthritis Res Ther (2017) 0.75
Taking into account the gender issue in cell death studies. Cell Death Dis (2014) 0.75
Overexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence. PLoS One (2015) 0.75
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum (1980) 21.86
Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet (1990) 19.57
Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA (1995) 15.80
Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med (1998) 11.27
4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res (2003) 4.41
The importance of glutathione in human disease. Biomed Pharmacother (2003) 3.61
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci U S A (1996) 2.88
Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity. J Biol Chem (1995) 2.69
4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 2.38
Pathogenic roles of B cells in human autoimmunity; insights from the clinic. Immunity (2004) 1.79
Genetically altered mice to evaluate glutathione homeostasis in health and disease. Free Radic Biol Med (2004) 1.76
Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling. Acta Biochim Pol (2003) 1.67
Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. Blood (2004) 1.57
Role of 4-hydroxynonenal in stress-mediated apoptosis signaling. Mol Aspects Med (2003) 1.57
Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin. Biochemistry (2000) 1.55
Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus (1997) 1.52
Lymphocyte surface thiol levels. Proc Natl Acad Sci U S A (2003) 1.52
Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress. J Biol Chem (2001) 1.49
Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy. Epilepsia (2007) 1.43
Apoptosis in the vasculature: mechanisms and functional importance. Br J Pharmacol (2000) 1.38
RLIP76 is a major determinant of radiation sensitivity. Cancer Res (2005) 1.37
Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum (2000) 1.33
Regression of melanoma in a murine model by RLIP76 depletion. Cancer Res (2006) 1.31
Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance. Int J Cancer (2003) 1.30
Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J Clin Invest (1999) 1.30
Role of mitogen-activated protein kinases in 4-hydroxy-2-nonenal-induced actin remodeling and barrier function in endothelial cells. J Biol Chem (2003) 1.28
4-hydroxynonenal induces mitochondrial oxidative stress, apoptosis and expression of glutathione S-transferase A4-4 and cytochrome P450 2E1 in PC12 cells. Toxicol Appl Pharmacol (2006) 1.19
Identification of membrane-anchoring domains of RLIP76 using deletion mutant analyses. Biochemistry (2004) 1.12
Cloning and expression of a cDNA encoding an elongation factor 1beta/delta protein from Echinococcus granulosus with immunogenic activity. Parasite Immunol (1999) 1.11
Role of apoptosis in atherosclerosis and its therapeutic implications. Clin Sci (Lond) (2004) 1.11
Cells preconditioned with mild, transient UVA irradiation acquire resistance to oxidative stress and UVA-induced apoptosis: role of 4-hydroxynonenal in UVA-mediated signaling for apoptosis. J Biol Chem (2003) 1.10
The role of endothelial cell apoptosis in inflammatory and immune diseases. J Thromb Haemost (2005) 1.06
Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype. J Neuropathol Exp Neurol (1998) 1.02
Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity. Int J Oncol (2003) 1.01
Apoptosis signalling by 4-hydroxynonenal: a role for JNK-c-Jun/AP-1 pathway. Redox Rep (2007) 1.01
RLIP76 is the major ATP-dependent transporter of glutathione-conjugates and doxorubicin in human erythrocytes. Arch Biochem Biophys (2001) 1.01
Trapping of 4-hydroxynonenal by glutathione efficiently prevents formation of DNA adducts in human cells. Free Radic Biol Med (2007) 0.96
RLIP76, a non-ABC transporter, and drug resistance in epilepsy. BMC Neurosci (2005) 0.94
Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Clin Rheumatol (2003) 0.93
Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies. Arthritis Res Ther (2004) 0.92
Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease. Arthritis Res Ther (2006) 0.91
Induction of endothelial cell apoptosis by the binding of anti-endothelial cell antibodies to Hsp60 in vasculitis-associated systemic autoimmune diseases. Arthritis Rheum (2005) 0.91
Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations. Arthritis Res Ther (2005) 0.90
Antigenic targets and pathogenicity of anti-aortic endothelial cell antibodies in Takayasu arteritis. Arthritis Rheum (2006) 0.89
Antiendothelial cell antibodies in vasculitis and connective tissue disease. Ann Rheum Dis (2006) 0.88
Transport functions and physiological significance of 76 kDa Ral-binding GTPase activating protein (RLIP76). Acta Biochim Pol (2002) 0.88
Fibroblast and endothelial apoptosis in systemic sclerosis. Curr Opin Rheumatol (2003) 0.87
New target antigens for anti-endothelial cell antibodies. Immunobiology (2005) 0.86
Humoral autoimmunity against endothelium: theory or reality? Trends Immunol (2005) 0.85
Allergen cross-reactivity between Pityrosporum orbiculare and Candida albicans. Allergy (1995) 0.85
Screening of a HUAEC cDNA library identifies actin as a candidate autoantigen associated with carotid atherosclerosis. Clin Exp Immunol (2004) 0.84
4-Hydroxy-2-nonenal is a powerful endogenous inhibitor of endothelial response. Biochem Biophys Res Commun (2001) 0.84
4. Autoimmunity, vasculitis, and autoantibodies. J Allergy Clin Immunol (2006) 0.84
Endothelium, a target for immune-mediated assault in connective tissue disease. Autoimmun Rev (2005) 0.79
Hypoxia-targeted bioreductive tyrosine kinase inhibitors with glutathione-depleting function. Anticancer Drugs (2006) 0.79
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis (2010) 10.03
Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells. Cancer Res (2006) 2.77
Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species. Cancer Res (2007) 1.83
Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther (2006) 1.78
Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli. EMBO Mol Med (2010) 1.72
Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol (2007) 1.70
Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome. Blood (2010) 1.67
Inflammation as "common soil" of the multifactorial diseases. Autoimmun Rev (2010) 1.57
Endosomal compartment contributes to the propagation of CD95/Fas-mediated signals in type II cells. Biochem J (2008) 1.53
An overview on the genetic of rheumatoid arthritis: a never-ending story. Autoimmun Rev (2011) 1.44
The effect of sex/gender on cardiovascular pharmacology. Curr Pharm Des (2011) 1.41
Echinococcus granulosus antigen B impairs human dendritic cell differentiation and polarizes immature dendritic cell maturation towards a Th2 cell response. Infect Immun (2007) 1.37
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. J Rheumatol (2007) 1.34
Human cystic echinococcosis: old problems and new perspectives. Interdiscip Perspect Infect Dis (2009) 1.29
Are the available experimental models of type 2 diabetes appropriate for a gender perspective? Pharmacol Res (2007) 1.22
The microenvironment can shift erythrocytes from a friendly to a harmful behavior: pathogenetic implications for vascular diseases. Cardiovasc Res (2007) 1.20
Estrogen receptor profiles in human peripheral blood lymphocytes. Immunol Lett (2010) 1.19
Cardiolipin-enriched raft-like microdomains are essential activating platforms for apoptotic signals on mitochondria. FEBS Lett (2009) 1.19
Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum (2007) 1.18
Role of autophagy in immunity and autoimmunity, with a special focus on systemic lupus erythematosus. FASEB J (2012) 1.18
Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther (2004) 1.18
Strong intra- and inter-continental differentiation revealed by Y chromosome SNPs M269, U106 and U152. Forensic Sci Int Genet (2010) 1.17
Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: a key role of ezrin. Lab Invest (2003) 1.17
Galectin-1 sensitizes resting human T lymphocytes to Fas (CD95)-mediated cell death via mitochondrial hyperpolarization, budding, and fission. J Biol Chem (2004) 1.17
Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis. J Immunol (2004) 1.17
High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation. Blood (2003) 1.16
"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum (2011) 1.15
Unraveling cancer chemoimmunotherapy mechanisms by gene and protein expression profiling of responses to cyclophosphamide. Cancer Res (2011) 1.13
CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization. J Immunol (2008) 1.13
Prion protein is a component of the multimolecular signaling complex involved in T cell activation. FEBS Lett (2004) 1.12
Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity. Int J Cancer (2010) 1.11
Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res Ther (2004) 1.10
Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress. J Neurochem (2002) 1.09
Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infection. J Immunol (2007) 1.07
Frequency of antibodies to mutated citrullinated vimentin in chronic obstructive pulmonary disease: comment on the article by Demoruelle et al. Arthritis Rheum (2013) 1.06
An update on immunodiagnosis of cystic echinococcosis. Acta Trop (2003) 1.06
Molecular cross-talk in host-parasite relationships: the intriguing immunomodulatory role of Echinococcus antigen B in cystic echinococcosis. Int J Parasitol (2008) 1.06
Chemotherapy and surgery in children with cystic echinococcosis. Pediatr Infect Dis J (2010) 1.05
Host-parasite relationship in cystic echinococcosis: an evolving story. Clin Dev Immunol (2011) 1.05
Clinical and ultrasonographic monitoring of response to adalimumab treatment in rheumatoid arthritis. J Rheumatol (2007) 1.04
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. Rheumatology (Oxford) (2011) 1.04
Oxidized beta2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response. Blood (2005) 1.04
Tissue transglutaminase is a multifunctional BH3-only protein. J Biol Chem (2004) 1.04
Autoimmune aspects of cytokine and anticytokine therapies. Am J Med (2003) 1.03
Autoantibodies to estrogen receptor α interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus. Arthritis Rheum (2012) 1.03